Table 4.

Multivariate analysis for the factors related to the efficacy of the ED on oral mucositis

Factor	p value	Hazard ratio	95 % CI
Prior administration of ED	0.023	99.423	1.879–5261
Dose reduction of 5-FU/oral fluoropyrimidine	0.034	1019.912	1.674–621,200
ED intake	0.039	1.015	1.001–1.030
Regimen 2 weeks (vs. 3 weeks)	0.051	5.886	0.986–3.418
Male	0.060	230.525	0.800–66,430
Pretreatment albumin value	0.094	75.445	0.482–11,820